Craig W Y, Palomaki G E, Haddow J E
Foundation for Blood Research, Scarborough, ME 04074.
BMJ. 1989 Mar 25;298(6676):784-8. doi: 10.1136/bmj.298.6676.784.
To examine the association between cigarette smoking in adults and serum lipid and lipoprotein concentrations the results of 54 published studies were analysed. Overall, smokers had significantly higher serum concentrations of cholesterol (3.0%), triglycerides (9.1%), very low density lipoprotein cholesterol (10.4%), and low density lipoprotein cholesterol (1.7%) and lower serum concentrations of high density lipoprotein cholesterol (-5.7%) and apolipoprotein AI (-4.2%) compared with nonsmokers. Among non-smokers and light, moderate, and heavy smokers a significant dose response effect was present for cholesterol (0, 1.8, 4.3, and 4.5% respectively), triglycerides (0, 10.7, 11.5, and 18.0%), very low density lipoprotein cholesterol (0, 7.2, 44.4, and 39.0%), low density lipoprotein cholesterol (0, -1.1, 1.4, and 11.0%), high density lipoprotein cholesterol (0, -4.6, -6.3, and -8.9%), and apolipoprotein AI (0, -3.7 and -5.7% in non-smokers and light and heavy smokers). These dose response effects may provide new evidence for a causal relation between exposure to cigarette smoke and changes in serum lipid and lipoprotein concentrations whether as a direct result of physiological changes or of dietary changes induced by smoking. Adequate prospective data to estimate the excess risk of coronary artery disease existed only for cholesterol concentration. When that information was combined with data from the present study, and given that smokers as a group face an average overall excess risk of coronary artery disease of 70%, it was estimated that the observed increased serum cholesterol concentration in smokers may account for at least 9% of that excess risk. Furthermore, the dose response effect of smoking on serum cholesterol concentration suggests a gradient of increased absolute risk of coronary artery disease between light and heavy smokers.
为研究成年人吸烟与血清脂质及脂蛋白浓度之间的关联,对54项已发表研究的结果进行了分析。总体而言,与不吸烟者相比,吸烟者的血清胆固醇浓度显著升高(3.0%)、甘油三酯浓度显著升高(9.1%)、极低密度脂蛋白胆固醇浓度显著升高(10.4%)、低密度脂蛋白胆固醇浓度显著升高(1.7%),而血清高密度脂蛋白胆固醇浓度显著降低(-5.7%)、载脂蛋白AI浓度显著降低(-4.2%)。在不吸烟者、轻度吸烟者、中度吸烟者和重度吸烟者中,胆固醇(分别为0、1.8%、4.3%和4.5%)、甘油三酯(分别为0、10.7%、11.5%和18.0%)、极低密度脂蛋白胆固醇(分别为0、7.2%、44.4%和39.0%)、低密度脂蛋白胆固醇(分别为0、-1.1%、1.4%和11.0%)、高密度脂蛋白胆固醇(分别为0、-4.6%、-6.3%和-8.9%)以及载脂蛋白AI(不吸烟者、轻度吸烟者和重度吸烟者分别为0、-3.7%和-5.7%)存在显著的剂量反应效应。这些剂量反应效应可能为接触香烟烟雾与血清脂质及脂蛋白浓度变化之间的因果关系提供新证据,无论这种变化是生理变化的直接结果还是吸烟引起的饮食变化的结果。仅胆固醇浓度有足够的前瞻性数据来估计冠状动脉疾病的额外风险。当该信息与本研究的数据相结合,且考虑到吸烟者作为一个群体面临的冠状动脉疾病总体平均额外风险为70%时,据估计吸烟者血清胆固醇浓度的升高可能至少占该额外风险的9%。此外,吸烟对血清胆固醇浓度的剂量反应效应表明,轻度吸烟者和重度吸烟者之间冠状动脉疾病的绝对风险增加存在梯度变化。